Impact of neoadjuvant treatment on total mesorectal excision for ultra-low rectal cancers

World Journal of Surgical Oncology

Volumn 8, Issue , 2010, Pages

  Lim, Yon K ^a   Law, Wai L ^a   Liu, Rico ^b   Poon, Jensen T C ^a   Fan, Joe F M ^a   Lo, Oswens S H ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; ANTINEOPLASTIC ANTIMETABOLITE;

ADJUVANT THERAPY; ADULT; AGED; ANUS SPHINCTER; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; COLORECTAL ANASTOMOSIS; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE; RECTUM ABDOMINOPERINEAL RESECTION; RECTUM CANCER; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; TISSUE PRESERVATION; TREATMENT RESPONSE; ABDOMINAL SURGERY; ADENOCARCINOMA; MIDDLE AGED; PATHOLOGY; RADIATION DOSE; RECTUM TUMOR; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; COMBINED MODALITY THERAPY; DIGESTIVE SYSTEM SURGICAL PROCEDURES; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; RADIOTHERAPY DOSAGE; RECTAL NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77952310022     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-8-23     Document Type: Article

References (38)

1. Nymann T, Jess P, Christiansen J. Rate and treatment of pelvic recurrence after abdominoperineal resection and low anterior resection for rectal cancer. Dis Colon Rectum 1995, 38:799-802. 10.1007/BF02049834, 7543403.
2. Madoff RD. Rectal cancer: optimum treatment leads to optimum results. Lancet 2009, 373:790-792. 10.1016/S0140-6736(09)60459-1, 19269501.
3. Enker WE. Total mesorectal excision--the new golden standard of surgery for rectal cancer. Ann Med 1997, 29:127-133.
4. Heald RJ, Moran BJ, Ryall RD, Sexton R, MacFarlane JK. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg 1998, 133:894-899. 10.1001/archsurg.133.8.894, 9711965.
5. Bolognese A, Cardi M, Muttillo IA, Barbarosos A, Bocchetti T, Valabrega S. Total mesorectal excision for surgical treatment of rectal cancer. J Surg Oncol 2000, 74:21-23. 10.1002/1096-9098(200005)74:1<21::AID-JSO5>3.0.CO;2-6, 10861603.
6. MacFarlane JK, Ryall RD, Heald RJ. Mesorectal excision for rectal cancer. Lancet 1993, 341:457-460. 10.1016/0140-6736(93)90207-W, 8094488.
7. Kuo LJ, Liu MC, Jian JJ, Horng CF, Cheng TI, Chen CM, Fang WT, Chung YL. Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy?. Ann Surg Oncol 2007, 14:2766-2772. 10.1245/s10434-006-9217-3, 17551794.
8. Shivnani AT, Small W, Stryker SJ, Kiel KD, Lim S, Halverson AL, Talamonti MS. Preoperative chemoradiation for rectal cancer: results of multimodality management and analysis of prognostic factors. Am J Surg 2007, 193:389-393. 10.1016/j.amjsurg.2006.09.030, 17320541.
9. Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, Rutten HJ, Pahlman L, Glimelius B, van Krieken JH, Leer JW, van der Velde V. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001, 345:638-646. 10.1056/NEJMoa010580, 11547717.
10. Bosset JF, Collette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, Daban A, Bardet E, Beny A, Ollier JC. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006, 355:1114-1123. 10.1056/NEJMoa060829, 16971718.
11. Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004, 351:1731-1740. 10.1056/NEJMoa040694, 15496622.
12. Camma C, Giunta M, Fiorica F, Pagliaro L, Craxi A, Cottone M. Preoperative radiotherapy for resectable rectal cancer: A meta-analysis. JAMA 2000, 284:1008-1015. 10.1001/jama.284.8.1008, 10944647.
13. Lee JH, Lee JH, Ahn JH, Bahng H, Kim TW, Kang YK, Lee KH, Kim JC, Yu CS, Kim JH, Ahn SD, Kim WK, Kim SH, Lee JS. Randomized trial of postoperative adjuvant therapy in stage II and III rectal cancer to define the optimal sequence of chemotherapy and radiotherapy: a preliminary report. J Clin Oncol 2002, 20:1751-1758. 10.1200/JCO.2002.07.037, 11919231.
14. Minsky BD, Cohen AM, Kemeny N, Enker WE, Kelsen DP, Reichman B, Saltz L, Sigurdson ER, Frankel J. Combined modality therapy of rectal cancer: decreased acute toxicity with the preoperative approach. J Clin Oncol 1992, 10:1218-1224.
15. Wagman R, Minsky BD, Cohen AM, Guillem JG, Paty PP. Sphincter preservation in rectal cancer with preoperative radiation therapy and coloanal anastomosis: long term follow-up. Int J Radiat Oncol Biol Phys 1998, 42:51-57.
16. Santiago RJ, Metz JM, Hanh S. Chemoradiotherapy in the treatment of rectal cancer. Hematol Oncol Clin North Am 2002, 16:995-1014. viii., 10.1016/S0889-8588(02)00037-0, 12418059.
17. Marijnen CA, Kapiteijn E, van D, Martijn H, Steup WH, Wiggers T, Kranenbarg EK, Leer JW. Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol 2002, 20:817-825. 10.1200/JCO.20.3.817, 11821466.
18. Holm T, Rutqvist LE, Johansson H, Cedermark B. Postoperative mortality in rectal cancer treated with or without preoperative radiotherapy: causes and risk factors. Br J Surg 1996, 83:964-968. 10.1002/bjs.1800830725, 8813788.
19. Law WL, Chu KW. Impact of total mesorectal excision on the results of surgery of distal rectal cancer. Br J Surg 2001, 88:1607-1612. 10.1046/j.0007-1323.2001.01929.x, 11736973.
20. Law WL, Chu KW. Abdominoperineal resection is associated with poor oncological outcome. Br J Surg 2004, 91:1493-1499. 10.1002/bjs.4723, 15455362.
21. Heald RJ, Smedh RK, Kald A, Sexton R, Moran BJ. Abdominoperineal excision of the rectum--an endangered operation. Norman Nigro Lectureship. Dis Colon Rectum 1997, 40:747-751. 10.1007/BF02055425, 9221846.
22. Scott N, Jackson P, al-Jaberi T, Dixon MF, Quirke P, Finan PJ. Total mesorectal excision and local recurrence: a study of tumour spread in the mesorectum distal to rectal cancer. Br J Surg 1995, 82:1031-1033. 10.1002/bjs.1800820808, 7648142.
23. Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986, 1:1479-1482. 10.1016/S0140-6736(86)91510-2, 2425199.
24. Law WL, Chu KW. Anterior resection for rectal cancer with mesorectal excision: a prospective evaluation of 622 patients. Ann Surg 2004, 240:260-268. 10.1097/01.sla.0000133185.23514.32, 1356402, 15273550.
25. Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, Rutten HJ, Pahlman L, Glimelius B, van Krieken JH, Leer JW, van der Velde CJ. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001, 345:638-646. 10.1056/NEJMoa010580, 11547717.
26. Bosset JF, Collette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, Daban A, Bardet E, Beny A, Ollier JC. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006, 355:1114-1123. 10.1056/NEJMoa060829, 16971718.
27. Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004, 351:1731-1740. 10.1056/NEJMoa040694, 15496622.
28. Wong RK, Tandan V, De SS, Figueredo A. Pre-operative radiotherapy and curative surgery for the management of localized rectal carcinoma. Cochrane Database Syst Rev 2007, CD002102.
29. Watanabe T. Chemoradiotherapy and adjuvant chemotherapy for rectal cancer. Int J Clin Oncol 2008, 13:488-497. 10.1007/s10147-008-0849-0, 19093175.
30. Han N, Galandiuk S. Induction chemoradiation for rectal cancer. Arch Surg 2006, 141:1246-1252. 10.1001/archsurg.141.12.1246, 17178968.
31. Shivnani AT, Small W, Stryker SJ, Kiel KD, Lim S, Halverson AL, Talamonti MS. Preoperative chemoradiation for rectal cancer: results of multimodality management and analysis of prognostic factors. Am J Surg 2007, 193:389-393. 10.1016/j.amjsurg.2006.09.030, 17320541.
32. Kuo LJ, Liu MC, Jian JJ, Horng CF, Cheng TI, Chen CM, Fang WT, Chung YL. Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy?. Ann Surg Oncol 2007, 14:2766-2772. 10.1245/s10434-006-9217-3, 17551794.
33. Marijnen CA, Kapiteijn E, van D, Martijn H, Steup WH, Wiggers T, Kranenbarg EK, Leer JW. Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol 2002, 20:817-825. 10.1200/JCO.20.3.817, 11821466.
34. Enker WE, Merchant N, Cohen AM, Lanouette NM, Swallow C, Guillem J, Paty P, Minsky B, Weyrauch K, Quan SH. Safety and efficacy of low anterior resection for rectal cancer: 681 consecutive cases from a specialty service. Ann Surg 1999, 230:544-552. 10.1097/00000658-199910000-00010, 1420903, 10522724.
35. Urso E, Serpentini S, Pucciarelli S, De Salvo GL, Friso ML, Fabris G, Lonardi S, Ferraro B, Bruttocao A, Aschele C, Nitti D. Complications, functional outcome and quality of life after intensive preoperative chemoradiotherapy for rectal cancer. Eur J Surg Oncol 2006, 32:1201-1208. 10.1016/j.ejso.2006.07.003, 16872799.
36. Sebag-Montefiore D, Stephens RJ, Steele R, Monson J, Grieve R, Khanna S, Quirke P, Couture J, de MC, Myint AS, Bessell E, Griffiths G, Thompson LC, Parmar M. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet 2009, 373:811-820. 10.1016/S0140-6736(09)60484-0, 2668947, 19269519.
37. Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Michalski W, Bebenek M, Pudelko M, Kryj M, Oledzki J, Szmeja J, Sluszniak J, Serkies K, Kladny J, Pamucka M, Kukolowicz P. Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy. Radiother Oncol 2004, 72:15-24. 10.1016/j.radonc.2003.12.006, 15236870.
38. Rosati R, Bona S, Romario UF, Elmore U, Furlan N. Laparoscopic total mesorectal excision after neoadjuvant chemoradiotherapy. Surg Oncol 2007, 16(Suppl 1):S83-S89. 10.1016/j.suronc.2007.10.033, 18042378.